Reg4 deficiency aggravates pancreatitis by increasing mitochondrial cell death and fibrosis
Regenerating gene family member 4 ( Reg4 ) has been implicated in acute pancreatitis, but its precise functions and involved mechanisms have remained unclear. Herein, we sought to investigate the contribution of Reg4 to the pathogenesis of pancreatitis and evaluate its therapeutic effects in experim...
Gespeichert in:
Veröffentlicht in: | Cell death & disease 2024-05, Vol.15 (5), p.348-348, Article 348 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Regenerating gene family member 4 (
Reg4
) has been implicated in acute pancreatitis, but its precise functions and involved mechanisms have remained unclear. Herein, we sought to investigate the contribution of
Reg4
to the pathogenesis of pancreatitis and evaluate its therapeutic effects in experimental pancreatitis. In acute pancreatitis,
Reg4
deletion increases inflammatory infiltrates and mitochondrial cell death and decreases autophagy recovery, which are rescued by the administration of recombinant
Reg4
(
rReg4
) protein. In chronic pancreatitis,
Reg4
deficiency aggravates inflammation and fibrosis and inhibits compensatory cell proliferation. Moreover, C-X-C motif ligand 12 (CXCL12)/C-X-C motif receptor 4 (CXCR4) axis is sustained and activated in
Reg4
-deficient pancreas. The detrimental effects of
Reg4
deletion are attenuated by the administration of the approved CXCR4 antagonist plerixafor (AMD3100). Mechanistically,
Reg4
mediates its function in pancreatitis potentially via binding its receptor exostosin-like glycosyltransferase 3 (
Extl3
). In conclusion, our findings suggest that
Reg4
exerts a therapeutic effect during pancreatitis by limiting inflammation and fibrosis and improving cellular regeneration. |
---|---|
ISSN: | 2041-4889 2041-4889 |
DOI: | 10.1038/s41419-024-06738-y |